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Abstract
Background: Prepregnancy obesity is associated with increased risk for adverse pregnancy outcome such as
gestational diabetes mellitus (GDM), gestational hypertension, preeclampsia, fetal macrosomia and the need for
cesarean delivery. The objectives of this study assessed whether Thai women classified as obese according to
WHO’s recommended body mass index (BMI) for Asians were at risk for developing gestational diabetes mellitus
(GDM) and other complications such as preeclampsia, gestational hypertension and fetal macrosomia.
Methods: Two hundred and forty women participated in this study and followed prospectively until delivery. Half
of the women (n = 120) were obese (BMI ≥ 27.5 kg/m
2) and the other half (n = 120) had normal weight (BMI >
18.5-23 kg/m
2). Maternal demographic data, obstetric and neonatal outcomes from both groups were compared to
each other. Relative risk and 95% confidence interval (CI) were calculated.
Results: Compared to normal weight women, obese Thai women were not at increased risk for gestational
diabetes mellitus (RR = 0.9 [95% CI 0.6-1.4]). Relative risk of preeclampsia and fetal macrosomia in obese women
were 0.7 [95% CI 0.2-3.3] and 1.4 [95% CI 0.5-4.3], respectively. Relative risk of gestational hypertension in obese
women was 12 [95% CI 1.6-90.8].
Conclusion: When WHO’s classification of obesity was used for Asian populations, prepregnancy obesity without
metabolic problems did not increase the risk for GDM, preeclampsia and fetal macrosomia in Thai women. But,
prepregnancy obesity continued to increase the risk for developing gestational hypertension.
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Background
Obesity is a major public health concern and its impact
on pregnancy continues to grow in the world as well as
in Thailand. The prevalence of obesity in Thailand has
doubled in the past two decades. The prevalence of obe-
sity in women with BMI ≥ 25 kg/m
2 increased from
23.2% in 1991 to 29.5% in 1997 and 34.3% in 2004
respectively [1]. Obesity contributes to significantly
affect morbidity and mortality for several conditions
such as heart disease, diabetes mellitus and
hypertension.
There is an increase in number of interrelated adverse
perinatal outcomes in obese women who become preg-
nant. Several studies have reported that maternal obesity
is associated with increased risk for adverse pregnancy
outcome such as gestational diabetes mellitus (GDM),
gestational hypertension, preeclampsia, fetal macrosomia
and the need for cesarean delivery [2-6]. Marked obesity
is unequally hazardous to the pregnant woman and her
fetus [7,8].
Most of these studies were performed in developed
countries and its data may not applicable to the Asian
population because Asians naturally have a lower body
mass index (BMI), percentage of body fat, and health
risks compared to Caucasians. As a result of this, WHO
has adjusted its BMI recommendation for the Asian
population [9]. Three specific factors led WHO to con-
vene another expert consultation on BMI classifications.
First, there was increasing evidence of the emerging
high prevalence of type 2 diabetes and increased cardio-
vascular risk factors in parts of Asia where the average
BMI is below the cut-off point of 25 kg/m
2 that defines
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increasing evidence that the associations between BMI,
percentage of body fat, and body fat distribution differ
across populations. Third, there had been previous
attempts to interpret the WHO BMI cut-offs in Asian
and Pacific populations, which contributed to the grow-
ing debates on whether there are possible needs for
developing different BMI cut-off points for different eth-
nic groups [9,10]. Therefore, we conducted a hospital-
based prospective study to investigate the effect of
maternal prepregnancy obesity on pregnancy outcomes.
The primary objective of this study assessed the risk for
developing GDM in Thai women who were classified as
obese according to WHO’s recommended BMI for
Asians. The secondary objective assessed other compli-
cations such as preeclampsia, gestational hypertension
and fetal macrosomia.
Methods
This study was approved by the Research Ethics Com-
mittee of the Faculty of Medicine, Chulalongkorn Uni-
versity. This study prospectively evaluates women with
singleton pregnancies who attended antenatal clinic at
King Chulalongkorn Memorial Hospital, Bangkok, Thai-
land before 28 weeks gestation between April 1, 2009
and April 30, 2010. Women between the age of 20-34
years attending antenatal clinics for the first time with
no chronic medical illness, no history of GDM and pre-
eclampsia, no family history of diabetes mellitus, and no
history of fetal macrosomia (birth weight ≥ 4,000 g)
were recruited into the study. Women with unknown
body weight prior to pregnancy and had metabolic syn-
drome were excluded. Informed consent forms were
signed by all eligible women prior to entering. The
women were divided into 2 groups according to their
prepregnancy BMI; women with normal BMI (18.5-23
kg/m
2) became the controls whereas the obese women
(BMI ≥ 27.5 kg/m
2) joined the study group [9].
The sample size calculation was based on relative risks
of primary and secondary outcomes obtained from our
pilot study. We found that relative risks of preeclampsia
gave the largest sample size. Thus, we needed 120
women in each group to detect a statistical difference (a
= 0.05, b = 0.1).
At w o - s t e pd i a g n o s t i cp r o c e d u r eu s i n ga5 0 - gg l u c o s e
challenge test and a 100-g oral glucose tolerance test
(OGTT) was used to diagnose GDM. 50-g glucose chal-
lenge test was performed at 24-28 weeks gestation.
Plasma glucose ≥ 140 mg/dl was considered a positive
result and was referred for a diagnostic 100-g oral glu-
cose tolerance test (OGTT). GDM was defined as hav-
ing > 2 plasma glucose values equal to or above the
NDDG cut-off values (105, 190, 165, 145 mg/dL) [7].
Preeclampsia was defined as a new onset hypertension
(BP ≥ 140/90 mmHg after 20 weeks gestation) and pro-
teinuria ≥ 300 mg/24 hour or ≥ 1+ dipstick which
regressed postpartum [7]. Gestational hypertension was
defined as a new onset hypertension during pregnancy
without any proteinuria which regressed postpartum [7].
The appropriate size of cuff was used to measure blood
pressure. Fetal macrosomia was defined as fetal birth
weight ≥ 4,000 gm [7].
Maternal age, parity, gestational age at first antenatal
care and delivery, complications during pregnancy and
delivery and neonatal outcomes were recorded.
Statistical analysis was performed by using SPSS soft-
ware package version 12.0 (SPSS Inc, Chicago, IL, USA).
Descriptive statistics was used and presented as mean,
standard deviation, and frequency. Continuous variables
w e r ec o m p a r e db ys t u d e n ttt e s ta n dM a n n - W h i t n e yU
test. Chi square test (or Fisher exact test when appropri-
ate) was used to compare categorical variables. Univari-
ate and multivariate logistic regressions were used to
explore the relationships between BMI and risk of out-
comes; the results of the analysis were expressed as rela-
tive risk (RR) with 95% confidence interval (CI). A P-
value < 0.05 was considered statistically significant.
Results
A total of 240 women were enrolled in this study; 120
women had normal BMI and 120 women were obese.
The demographic characteristics of women according to
their BMI are summarized in Table 1. There were no
significant differences for age, parity, and gestational age
at delivery. Obese women weighted more, were taller
and had a higher BMI compared to the women with
normal BMI. But, the women with normal BMI gain
more weight during pregnancy compared to the obese
women.
Table 1 Demographic characteristics according to
prepregnancy BMI
Characteristics Normal
(N = 120)
Obese
(N = 120)
P-value
Age 29.9 ± 3.5 28.2 ± 3.6 0.52
Parity* 1 1 0.098
Weight (kg) 51.8 ± 5.0 82.6 ± 11.6 < 0.001
Height (cm) 157.6 ± 5.4 159.0 ± 4.9 0.035
BMI (kg/m
2) 20.8 ± 1.4 32.6 ± 3.8 < 0.001
TWG (kg) 16.0 ± 4.4 12.2 ± 5.7 < 0.001
Gestational age at 1
stANC visit
(weeks)
12.4 ± 5.6 15.2 ± 7.2 0.001
Gestational age at delivery
(weeks)
38.8 ± 1.1 38.8 ± 1.2 0.955
No. of ANC visits (times) 10.2 ± 2.3 9.3 ± 2.6 0.003
Data presented as mean ± SD or *median
TWG: total weight gain, ANC: antenatal care
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Table 2. The rates of GDM, preeclampsia, preterm
delivery, premature rupture of membranes (PROM),
postpartum hemorrhage (PPH) and cesarean delivery
were not different between both groups. Gestational
hypertension occurred more frequently in the obese
women compared to the controls (10% vs 0.9%, P =
0.004). Twenty-two (18.3%) cases of normal women and
23 (19.2%) cases of obese women need medication for
c o n t r o ld i a b e t e s .A l lo ft h e s ew o m e nh a v eg o o dc o n t r o l
diabetes.
Neonatal outcomes between both groups are shown in
Table 3. Birth weight was significantly higher in the
obese women when compared to the controls. There
were no significant differences between both groups for
macrosomia, prematurity, Apgar scores at 1 and 5
minutes, and neonatal complications. There were no
stillbirths in this study.
Relative risks of pregnancy outcomes are shown in
Table 4. Only relative risk for gestational hypertension
was considered significant (12, [95% CI 1.6-90.8]).
Discussion
This study evaluated the effect of obesity on pregnancy
outcomes based on BMI for Asians. According to
WHO’S BMI criteria, the range for normal BMI was
18.5-23 kg/m
2 whereas BMI ≥ 27.5 kg/m
2 was consid-
ered obese [9]. We did not find any association between
obesity and gestational diabetes, preeclampsia, fetal
macrosomia and the need for cesarean delivery. Our
findings were similar to the results obtained from a
South African study [11]. They also did not find any
risk of gestational diabetes, preeclampsia, fetal macroso-
m i aa n dt h en e e df o rc e s a r e a nd e l i v e r yi nt h e i ro b e s e
women. They stated that complications associated gesta-
tional diabetes, preeclampsia, fetal macrosomia and the
need for cesarean delivery were more commonly seen
among morbidly obese women.
Furthermore, in present study, we found that gesta-
tional hypertension was significantly higher in obese
Thai women. This finding corroborates data from
another study conducted by Doherty et al [3]. However,
we did not control for the risk factors of gestational
hypertension. Thus, it may be difficult to interpret these
results.
In contrast to these findings, results from previous ret-
rospective studies [3-6,12], showed obese women having
an increased risk for developing gestational diabetes,
preeclampsia, fetal macrosomia and required cesarean
delivery. The reason of this difference is due to the dif-
ferent BMI cut-off used to define obesity. In addition,
obese women in present study controlled their diet dur-
ing pregnancy. It has been shown that gestational weight
gain during pregnancy is associated with adverse out-
comes such as GDM, preeclampsia [13,14]. A study
from Jain et al confirmed that the Institute of Medicine
weight gain recommendation helped to achieve better
pregnancy outcomes in obese and overweight women
[15].
In another study conducted by Sahu et al [16], they
showed that obesity was significantly associated with
Table 2 Prepregnancy body mass index and maternal
outcomes
Normal
(N = 120)
Obese
(N = 120)
P-value
GDM 0.69
-A 1 14 (11.7%) 10 (8.3%)
-A 2 22 (18.3%) 23 (19.2%)
Preeclampsia 4 (3.5%) 3 (2.5%) 1.000
Gestational hypertension 1 (0.9%) 12 (10%) 0.004
Preterm delivery 4 (3.3%) 4 (3.3%) 1.000
PROM 7 (5.8%) 9 (7.5%) 0.605
PPH 1 (0.8%) 2 (1.7%) 1.000
Cesarean delivery 52 (45.6%) 64 (53.3%) 0.238
Cesarean delivery due to CPD 23 (44.2%) 36 (56.3%) 0.051
Data presented as n (%)
GDM: gestational diabetes mellitus, PROM: premature ruptures of membranes,
PPH: postpartum hemorrhage, CPD: cephalopelvic disproportion
Table 3 Prepregnancy body mass index and neonatal
outcomes
Normal
(N = 120)
Obese
(N = 120)
P-value
Birth weight (g) 3178.9 ± 424.6 3322.5 ± 407.2 0.008
Macrosomia (BW ≥ 4,000 g) 5 (4.2%) 7 (5.8%) 0.554
Prematurity 4 (3.3%) 4 (3.3%) 1.000
Apgar scores at 1 min 8.8 ± 0.6 8.7 ± 0.7 0.55
Apgar scores at 5 min 9.9 ± 0.8 9.9 ± 1.1 0.798
NICU admission rate 00 N A
Neonatal complications
- Hypoglycemia 00 N A
- Infection 0 1 (0.8%) 1.000
- RDS 0 2 (1.7%) 0.498
- Hyperbilirubinemia 23 (19.2%) 15 (12.5%) 0.157
- Stillbirths0 0 N A
Data presented as mean ± SD or n (%)
NICU: neonatal intensive care unit, RDS: respiratory distress syndrome
Table 4 Relative risks of pregnancy outcomes
Relative risks 95%CI
GDM 0.9 0.6-1.4
Preeclampsia 0.7 0.2-3.3
Gestational hypertension 12 1.6-90.8
Macrosomia 1.4 0.5-4.3
GDM: gestational diabetes mellitus
Kongubol and Phupong BMC Pregnancy and Childbirth 2011, 11:59
http://www.biomedcentral.com/1471-2393/11/59
Page 3 of 4preeclampsia. But, we did not find the association
between obesity and preeclampsia (RR 0.7, 95%CI 0.2-
3.3) in present study.
As for neonatal outcomes, we did not find any differ-
ence between both groups for macrosomia, prematurity,
or any other neonatal complications. This may be due
to the fact that our obese women controlled their diet
during pregnancy. This finding corroborates data from
another study [17].
The strength of this study was its prospective nature.
This allowed us to freely collect all data needed for the
study and exclude confounding factors such as family
history of diabetes, previous history of gestational dia-
betes. The other strength was that WHO’s classification
for obesity for Asians was never been used for evalua-
tion the pregnancy outcomes. Unfortunately, one of the
limitations of this study was its small case of some
complications.
Conclusions
When WHO’s classification for obesity was used for
Asians, prepregnancy obesity without metabolic pro-
blems did not increase risk for developing GDM, pree-
clampsia, fetal macrosomia nor require the need for a
cesarean delivery. However, physicians should note that
prepregnancy obesity can increases risk for developing
gestational hypertension.
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